Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines is a late-stage clinical oncology company seeking a Research Associate II to support mass spectrometry-based proteomics workflows. The ideal candidate will have a bachelor's degree in biology, biochemistry, or a related field, and 3-5 years of hands-on laboratory experience.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
CellCarta